Biomarin Pharmaceutical (BMRN) Assets (2009 - 2026)
Biomarin Pharmaceutical (BMRN) reported Assets of $11.72 billion for Q2 2026, up 57.2% from $7.46 billion a year earlier and up 36.5% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical posted Assets of $7.59 billion, up 8.7% from FY2024.
- Assets has increased for seven consecutive years, with a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
- By year, Assets came in at $6.99 billion in FY2024 (+2.2%), $6.84 billion in FY2023 (+7.3%), $6.38 billion in FY2022 (+6.2%) and $6 billion in FY2021 (+2.7%).
- The Q2 2026 figure ranks as the highest quarterly Assets in data going back to Q4 2009.
- Year over year, Assets has now increased in each of the last 19 quarters, with growth averaging 13.8% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q2 2026 (growth of 57.2%); the low point was Q3 2021 (a decline of 2.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.59 billion (Q1 2026), $7.59 billion (Q4 2025) and $7.61 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.82 Bn | 1,105.41 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 617.41 Bn | 535.94 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 501.29 Bn | 474.40 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.07 Bn | 261.06 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 236.34 Bn | 191.74 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.00 Bn | 165.20 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Biomarin Pharmaceutical | 10.73 Bn | 4.60 Bn | 786.91 Mn | 11.72 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.72 Bn |
| Mar 31, 2026 | 8.59 Bn |
| Dec 31, 2025 | 7.59 Bn |
| Sep 30, 2025 | 7.61 Bn |
| Jun 30, 2025 | 7.46 Bn |
| Mar 31, 2025 | 7.15 Bn |
| Dec 31, 2024 | 6.99 Bn |
| Sep 30, 2024 | 6.85 Bn |
| Jun 30, 2024 | 7.07 Bn |
| Mar 31, 2024 | 6.87 Bn |
| Dec 31, 2023 | 6.84 Bn |
| Sep 30, 2023 | 6.76 Bn |
| Jun 30, 2023 | 6.56 Bn |
| Mar 31, 2023 | 6.43 Bn |
| Dec 31, 2022 | 6.38 Bn |
| Sep 30, 2022 | 6.26 Bn |
| Jun 30, 2022 | 6.15 Bn |
| Mar 31, 2022 | 6.06 Bn |
| Dec 31, 2021 | 6.00 Bn |
| Sep 30, 2021 | 5.98 Bn |
API Access
Biomarin Pharmaceutical Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();